Tuesday, February 17, 2026 2/17/2026

Mechanisms for somatodendritic dopamine release in the midbrain

Award Number: R01DA056109
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/15/2023
PERIOD OF PERFORMANCE END DATE: 12/31/2027

Group Awards By:

View Award Description

Mechanisms for somatodendritic dopamine release in the midbrain - Summary Many central neurons release neuromodulatory transmitters, for example monoamines, neuropeptides, and neurotrophins, from their somata and dendrites. Release of these transmitters is followed by G-protein coupled receptor activation, and these neuromodulator pathways are essential for brain development and function. Dopamine signaling in the ventral midbrain is a prominent example of this transmission mode, and it is particularly important for the response to drugs of abuse. The knowledge of somatodendritic release and G-protein coupled receptor-mediated transmission lags far behind that of synaptic signaling, but it is often considered slow and imprecise. The long-term goal of this project is to determine the molecular mechanisms that mediate somatodendritic dopamine transmission. We hypothesize that somatodendritic dopamine secretion is mediated by mechanistically specialized machinery for fast and synchronous release. We propose that this machinery is assembled into release hotspots to generate a signal with rapid kinetics that is directed towards G-protein coupled receptor domains on target cells, an architecture ideally suited for robust receptor activation. Our recent work has made first progress towards this goal. We have found that RIM, a protein important for the spatiotemporal precision of axonal transmitter release, is essential for evoked somatodendritic dopamine release. Furthermore, we found that synaptotagmin-1, a fast Ca2+ sensor, mediates Ca2+-triggering of this form of release. We here propose to determine the organization and function of somatodendritic dopamine release machinery using conditional mouse gene knockout, electrophysiology, imaging and superresolution microscopy. In aim 1, we propose to dissect somatodendritic release site architecture in midbrain dopamine neurons. We will systematically test the necessity and localization of five key active zone protein families that control speed and location of exocytosis at classical synapses. In aim 2, we propose to identify Ca2+ sources and sensors for somatodendritic dopamine release. We will assess conditional mouse mutants that lack Ca2+ channel or Ca2+ sensor proteins for secretory deficits and will assess the localization of the proteins needed for Ca2+-triggering in the somatodendritic compartments. These aims will define mechanisms of Ca2+-triggering and are likely to identify active zone-like release hotspots. Our work will further reveal shared and distinct release mechanisms in somatodendritic and axonal compartments of dopamine neurons. This multi-PI project will advance the understanding of somatodendritic dopamine signaling in the midbrain specifically, and of G-protein coupled receptor-mediated transmission in general. It combines the expertise of the laboratories of John Williams and Pascal Kaeser. In-depth studies of these mechanisms will allow us to derive principles and specifications of these neuronal secretory pathways and may ultimately help advancing treatments for diseases with disrupted dopamine function, for example drug addiction.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $581,175 )
2026	2026	PRESIDENT AND FELLOWS OF HARVARD COLLEGE	25 SHATTUCK ST	BOSTON	MA	02115	SUFFOLK	USA	Drug Use and Addiction Research Programs	000	4	2/11/2026	NON-COMPETING CONTINUATION	$581,175
														Subtotal = $581,175

Issue Date FY: 2025 ( Subtotal = $581,175 )
2025	2025	PRESIDENT AND FELLOWS OF HARVARD COLLEGE	25 SHATTUCK ST	BOSTON	MA	02115	SUFFOLK	USA	Drug Use and Addiction Research Programs	001	3	4/7/2025	NON-COMPETING CONTINUATION	$58,118
2025	2025	PRESIDENT AND FELLOWS OF HARVARD COLLEGE	25 SHATTUCK ST	BOSTON	MA	02115	SUFFOLK	USA	Drug Use and Addiction Research Programs	000	3	1/9/2025	NON-COMPETING CONTINUATION	$523,057
														Subtotal = $581,175

Issue Date FY: 2024 ( Subtotal = $581,175 )
2024	2024	PRESIDENT AND FELLOWS OF HARVARD COLLEGE	25 SHATTUCK ST	BOSTON	MA	02115	SUFFOLK	USA	Drug Use and Addiction Research Programs	000	2	12/12/2023	NON-COMPETING CONTINUATION	$523,057
2024	2024	PRESIDENT AND FELLOWS OF HARVARD COLLEGE	25 SHATTUCK ST	BOSTON	MA	02115	SUFFOLK	USA	Drug Use and Addiction Research Programs	001	2	4/24/2024	NON-COMPETING CONTINUATION	$58,118
														Subtotal = $581,175

Issue Date FY: 2023 ( Subtotal = $598,550 )
2023	2023	PRESIDENT AND FELLOWS OF HARVARD COLLEGE	25 SHATTUCK ST	BOSTON	MA	02115	SUFFOLK	USA	Drug Use and Addiction Research Programs	000	1	3/6/2023	NEW	$598,550
														Subtotal = $598,550

Grand Total All Awards = $2,342,075

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Mechanisms for somatodendritic dopamine release in the midbrain

Award Number: R01DA056109

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/15/2023

PERIOD OF PERFORMANCE END DATE: 12/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer